$2.88
0.35% today
Nasdaq, Apr 01, 06:35 pm CET
ISIN
US23666P1012
Symbol
DARE
Sector
Industry

Dare Bioscience, Inc. Stock price

$2.89
-0.25 7.96% 1M
-0.35 10.80% 6M
-0.23 7.37% YTD
-3.05 51.36% 1Y
-14.99 83.84% 3Y
-7.31 71.67% 5Y
-1,078.31 99.73% 10Y
Nasdaq, Closing price Mon, Mar 31 2025
+0.01 0.35%
ISIN
US23666P1012
Symbol
DARE
Sector
Industry

Key metrics

Market capitalization $25.14m
Enterprise Value $19.80m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 10.53
P/S ratio (TTM) P/S ratio 13.37
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 88.13%
Revenue (TTM) Revenue $1.88m
EBIT (operating result TTM) EBIT $-23.13m
Free Cash Flow (TTM) Free Cash Flow $-8.63m
Cash position $11.23m
EPS (TTM) EPS $-0.44
P/E forward negative
P/S forward 23.21
EV/Sales forward 18.26
Short interest 1.01%
Show more

Is Dare Bioscience, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Dare Bioscience, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Dare Bioscience, Inc. forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a Dare Bioscience, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Dare Bioscience, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1.88 1.88
88% 88%
100%
- Direct Costs 0.05 0.05
67% 67%
3%
1.84 1.84
90% 90%
98%
- Selling and Administrative Expenses 10 10
16% 16%
544%
- Research and Development Expense 15 15
52% 52%
781%
-23 -23
45% 45%
-1,228%
- Depreciation and Amortization 0.05 0.05
67% 67%
3%
EBIT (Operating Income) EBIT -23 -23
45% 45%
-1,230%
Net Profit -3.60 -3.60
91% 91%
-191%

In millions USD.

Don't miss a Thing! We will send you all news about Dare Bioscience, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Dare Bioscience, Inc. Stock News

Neutral
Seeking Alpha
about 15 hours ago
Daré Bioscience, Inc. (NASDAQ:DARE ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants MarDee Haring-Layton - Chief Accounting Officer Sabrina Martucci Johnson - President & Chief Executive Officer Conference Call Participants Catherine Novack - Jones Trading Douglas Tsao - H.C. Wainwright Kemp Dolliver - Brookline Capital Markets Operator Welcome to the conference...
Neutral
GlobeNewsWire
about 21 hours ago
With increasing demand for needed treatments designed for women, Daré is taking action to make its proprietary Sildenafil Cream formulation available via prescription this year With increasing demand for needed treatments designed for women, Daré is taking action to make its proprietary Sildenafil Cream formulation available via prescription this year
Neutral
GlobeNewsWire
8 days ago
SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and well-being of women, will host a conference call and live webcast at 4:30 p.m. Eastern Time on Monday, March 31, 2025, to review its financial results for the year ended December 31, 2024, and to provide a company update.
More Dare Bioscience, Inc. News

Company Profile

Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is headquartered in San Diego, CA.

Head office United States
CEO Sabrina Johnson
Employees 26
Founded 2015
Website www.darebioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today